| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |